ENDONOVO THERAPEUTICS, INC. — Regulation A 1-A/A

ENDONOVO THERAPEUTICS, INC. of Woodland Hills, CA filed a Regulation A 1-A/A with the SEC on 2023-06-14. Aggregate offering: $5.0M (Tier 2). Industry: Other.

Offering

• Filed: 2023-06-14
• Form: 1-A/A
• Accession: 0001493152-23-021216
• Tier: Tier 2
• Total aggregate offering: $5.0M
• Issuer portion: $5.0M
• Price per security: $0.0100
• Securities offered: Equity (common or preferred stock)
• Underwriter: JH Darbie & Co.
• Broker-dealer CRD: 136352
• Audit status: Audited
• Auditor: Rose, Snyder & Jacobs, LLP
• Jurisdictions: 52 states/territories

Issuer

• CIK: 0001528172
• Organized in: DE
• Incorporated: 2008
• Address: 6320 Canoga Avenue, Woodland Hills, CA, 91367
• Phone: 800-489-4774

Financial snapshot (as filed)

• Total assets: $1.2M
• Cash & equivalents: $11K
• Total liabilities: $25.6M
• Stockholder equity: $-24.4M
• Revenues: $88K
• Net income: $7.2M

People (1)

Other Reg A filings by this issuer (3)

More

• CIK 1528172 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search